(CRWD) Crowdstrike Holdings - Overview
Sector: TechnologyIndustry: Software - Infrastructure | Exchange NASDAQ (USA) | Currency USD | Market Cap: 108.592m | Total Return 0.2% in 12m
Stock: Endpoint Security, Cloud Security, Identity Protection, Data Protection
Total Rating 46
Risk 78
Buy Signal -0.90
| Risk 5d forecast | |
|---|---|
| Volatility | 53.1% |
| Relative Tail Risk | -2.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | -18.62 |
| Character TTM | |
|---|---|
| Beta | 1.561 |
| Beta Downside | 1.178 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.44% |
| CAGR/Max DD | 1.00 |
EPS (Earnings per Share)
Revenue
Description: CRWD Crowdstrike Holdings March 04, 2026
CrowdStrike Holdings, Inc. (CRWD) offers cybersecurity solutions globally. Their Falcon platform delivers cloud-based protection for endpoints, cloud workloads, identity, and data.
The company operates on a Software as a Service (SaaS) subscription model, a common revenue structure in the software industry. This model typically involves recurring revenue streams.
CrowdStrikes services include corporate endpoint and cloud workload security, managed security, identity protection, and threat intelligence. They also provide AI-powered automation and generative AI workload security, reflecting the evolving landscape of cyber threats.
To understand the full scope of CrowdStrikes market position and financial health, further analysis on platforms like ValueRay is recommended.
Headlines to watch out for
- Subscription growth fuels recurring revenue expansion
- Cloud security demand drives platform adoption
- Cybersecurity spending increases enterprise budgets
- AI integration enhances threat detection capabilities
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -183.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -1.09 > 1.0 |
| NWC/Revenue: 67.23% < 20% (prev 58.31%; Δ 8.92% < -1%) |
| CFO/TA 0.15 > 3% & CFO 1.61b > Net Income -183.2m |
| Net Debt (-4.41b) to EBITDA (111.7m): -39.49 < 3 |
| Current Ratio: 1.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (258.1m) vs 12m ago 4.54% < -2% |
| Gross Margin: 74.86% > 18% (prev 0.75%; Δ 7.41k% > 0.5%) |
| Asset Turnover: 48.63% > 50% (prev 45.44%; Δ 3.20% > 0%) |
| Interest Coverage Ratio: -6.06 > 6 (EBITDA TTM 111.7m / Interest Expense TTM 28.0m) |
Altman Z'' 1.22
| A: 0.29 (Total Current Assets 7.42b - Total Current Liabilities 4.18b) / Total Assets 11.09b |
| B: -0.12 (Retained Earnings -1.28b / Total Assets 11.09b) |
| C: -0.02 (EBIT TTM -169.8m / Avg Total Assets 9.89b) |
| D: -0.19 (Book Value of Equity -1.27b / Total Liabilities 6.61b) |
| Altman-Z'' Score: 1.22 = BB |
Beneish M -3.06
| DSRI: 0.99 (Receivables 1.36b/1.13b, Revenue 4.81b/3.95b) |
| GMI: 1.00 (GM 74.86% / 74.92%) |
| AQI: 0.98 (AQ_t 0.24 / AQ_t-1 0.24) |
| SGI: 1.22 (Revenue 4.81b / 3.95b) |
| TATA: -0.16 (NI -183.2m - CFO 1.61b) / TA 11.09b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of CRWD shares?
As of March 26, 2026, the stock is trading at USD 385.86 with a total of 3,095,948 shares traded.
Over the past week, the price has changed by -11.46%, over one month by +6.21%, over three months by -19.81% and over the past year by +0.24%.
Over the past week, the price has changed by -11.46%, over one month by +6.21%, over three months by -19.81% and over the past year by +0.24%.
Is CRWD a buy, sell or hold?
Crowdstrike Holdings has received a consensus analysts rating of 4.27.
Therefore, it is recommended to buy CRWD.
- StrongBuy: 27
- Buy: 12
- Hold: 11
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CRWD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 490.5 | 27.1% |
| Analysts Target Price | 490.5 | 27.1% |
CRWD Fundamental Data Overview March 21, 2026
P/E Forward = 90.0901
P/S = 22.567
P/B = 24.9589
P/EG = 3.5943
Revenue TTM = 4.81b USD
EBIT TTM = -169.8m USD
EBITDA TTM = 111.7m USD
Long Term Debt = 745.5m USD (from longTermDebt, last quarter)
Short Term Debt = 18.2m USD (from shortTermDebt, last quarter)
Debt = 820.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.41b USD (from netDebt column, last quarter)
Enterprise Value = 104.18b USD (108.59b + Debt 820.1m - CCE 5.23b)
Interest Coverage Ratio = -6.06 (Ebit TTM -169.8m / Interest Expense TTM 28.0m)
EV/FCF = 84.04x (Enterprise Value 104.18b / FCF TTM 1.24b)
FCF Yield = 1.19% (FCF TTM 1.24b / Enterprise Value 104.18b)
FCF Margin = 25.76% (FCF TTM 1.24b / Revenue TTM 4.81b)
Net Margin = -3.81% (Net Income TTM -183.2m / Revenue TTM 4.81b)
Gross Margin = 74.86% ((Revenue TTM 4.81b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 76.34% (prev 75.59%)
Tobins Q-Ratio = 9.40 (Enterprise Value 104.18b / Total Assets 11.09b)
Interest Expense / Debt = 0.92% (Interest Expense 7.55m / Debt 820.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -134.1m (EBIT -169.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.77 (Total Current Assets 7.42b / Total Current Liabilities 4.18b)
Debt / Equity = 0.19 (Debt 820.1m / totalStockholderEquity, last quarter 4.43b)
Debt / EBITDA = -39.49 (Net Debt -4.41b / EBITDA 111.7m)
Debt / FCF = -3.56 (Net Debt -4.41b / FCF TTM 1.24b)
Total Stockholder Equity = 3.91b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.85% (Net Income -183.2m / Total Assets 11.09b)
RoE = -4.68% (Net Income TTM -183.2m / Total Stockholder Equity 3.91b)
RoCE = -3.64% (EBIT -169.8m / Capital Employed (Equity 3.91b + L.T.Debt 745.5m))
RoIC = -2.88% (negative operating profit) (NOPAT -134.1m / Invested Capital 4.66b)
WACC = 11.39% (E(108.59b)/V(109.41b) * Re(11.47%) + D(820.1m)/V(109.41b) * Rd(0.92%) * (1-Tc(0.21)))
Discount Rate = 11.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.53%
[DCF] Terminal Value 71.34% ; FCFF base≈1.17b ; Y1≈1.44b ; Y5≈2.46b
[DCF] Fair Price = 114.9 (EV 24.74b - Net Debt -4.41b = Equity 29.15b / Shares 253.6m; r=11.39% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 86.09 | EPS CAGR: 40.85% | SUE: 0.40 | # QB: 0
Revenue Correlation: 99.10 | Revenue CAGR: 30.01% | SUE: 0.79 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.07 | Chg7d=-0.000 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=43
EPS current Year (2027-01-31): EPS=4.86 | Chg7d=+0.002 | Chg30d=+0.022 | Revisions Net=+22 | Growth EPS=+30.2% | Growth Revenue=+22.8%
EPS next Year (2028-01-31): EPS=6.18 | Chg7d=+0.002 | Chg30d=-0.001 | Revisions Net=+16 | Growth EPS=+27.1% | Growth Revenue=+21.6%
[Analyst] Revisions Ratio: +0.00 (17 Up / 17 Down within 30d for Next Quarter)
P/S = 22.567
P/B = 24.9589
P/EG = 3.5943
Revenue TTM = 4.81b USD
EBIT TTM = -169.8m USD
EBITDA TTM = 111.7m USD
Long Term Debt = 745.5m USD (from longTermDebt, last quarter)
Short Term Debt = 18.2m USD (from shortTermDebt, last quarter)
Debt = 820.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.41b USD (from netDebt column, last quarter)
Enterprise Value = 104.18b USD (108.59b + Debt 820.1m - CCE 5.23b)
Interest Coverage Ratio = -6.06 (Ebit TTM -169.8m / Interest Expense TTM 28.0m)
EV/FCF = 84.04x (Enterprise Value 104.18b / FCF TTM 1.24b)
FCF Yield = 1.19% (FCF TTM 1.24b / Enterprise Value 104.18b)
FCF Margin = 25.76% (FCF TTM 1.24b / Revenue TTM 4.81b)
Net Margin = -3.81% (Net Income TTM -183.2m / Revenue TTM 4.81b)
Gross Margin = 74.86% ((Revenue TTM 4.81b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 76.34% (prev 75.59%)
Tobins Q-Ratio = 9.40 (Enterprise Value 104.18b / Total Assets 11.09b)
Interest Expense / Debt = 0.92% (Interest Expense 7.55m / Debt 820.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -134.1m (EBIT -169.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.77 (Total Current Assets 7.42b / Total Current Liabilities 4.18b)
Debt / Equity = 0.19 (Debt 820.1m / totalStockholderEquity, last quarter 4.43b)
Debt / EBITDA = -39.49 (Net Debt -4.41b / EBITDA 111.7m)
Debt / FCF = -3.56 (Net Debt -4.41b / FCF TTM 1.24b)
Total Stockholder Equity = 3.91b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.85% (Net Income -183.2m / Total Assets 11.09b)
RoE = -4.68% (Net Income TTM -183.2m / Total Stockholder Equity 3.91b)
RoCE = -3.64% (EBIT -169.8m / Capital Employed (Equity 3.91b + L.T.Debt 745.5m))
RoIC = -2.88% (negative operating profit) (NOPAT -134.1m / Invested Capital 4.66b)
WACC = 11.39% (E(108.59b)/V(109.41b) * Re(11.47%) + D(820.1m)/V(109.41b) * Rd(0.92%) * (1-Tc(0.21)))
Discount Rate = 11.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.53%
[DCF] Terminal Value 71.34% ; FCFF base≈1.17b ; Y1≈1.44b ; Y5≈2.46b
[DCF] Fair Price = 114.9 (EV 24.74b - Net Debt -4.41b = Equity 29.15b / Shares 253.6m; r=11.39% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 86.09 | EPS CAGR: 40.85% | SUE: 0.40 | # QB: 0
Revenue Correlation: 99.10 | Revenue CAGR: 30.01% | SUE: 0.79 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.07 | Chg7d=-0.000 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=43
EPS current Year (2027-01-31): EPS=4.86 | Chg7d=+0.002 | Chg30d=+0.022 | Revisions Net=+22 | Growth EPS=+30.2% | Growth Revenue=+22.8%
EPS next Year (2028-01-31): EPS=6.18 | Chg7d=+0.002 | Chg30d=-0.001 | Revisions Net=+16 | Growth EPS=+27.1% | Growth Revenue=+21.6%
[Analyst] Revisions Ratio: +0.00 (17 Up / 17 Down within 30d for Next Quarter)